Healthcare News

ORION CORPORATION PRESS RELEASE 14 OCTOBER 2026 at 9.00 EEST         Orion publishes Interim Report for January–September 2026 and holds a webcast on 28 October 2026         Orion will publish...

ORION OYJ        LEHDISTÖTIEDOTE        14.10.2026 KLO 9.00         Orion julkaisee osavuosikatsauksen 1–9/2026 ja järjestää verkkolähetyksen 28.10.2026 Orion julkaisee osavuosikatsauksen...

Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026.

Phonak announces Roger On Sphere™, the world's first remote microphone powered by a DNN that separates speech from background noise in real time.

 -- Launch follows MHLW approval of IMCIVREE for acquired hypothalamic obesity and inclusion on Japan's National Health Insurance drug price list -- -- IMCIVREE is the first approved therapy in...

Orum announced that the first patient has been dosed in a Phase 1 clinical trial evaluating ORM-1153, the Company’s investigational CD123-GSPT1 DAC.

TRexBio Announces Closing of Initial Public Offering

Press release – No. 20 / 2026 Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases ...

Collaboration will combine Zealand Pharma’s expertise in metabolic health with Generate’s proprietary generative AI platform to create multispecific drug candidates with tailored biological functions ...

Mean weight reduction ranged from 1.5% to 3.2% at Day 29 across Cohorts 1-4, compared with 0.1% for pooled placebo.No severe or serious TEAEs, no TEAE-related dose modifications, and no TEAE-related...